Thoroughbred Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.64M Buy
7,106
+392
+6% +$96.8K 0.08% 211
2026
Q2
$1.62M Buy
6,714
+2,418
+56% +$530K 0.08% 219
2026
Q1
$812K Buy
+4,296
New +$751K 0.05% 319

Other funds holding JAZZ

Thoroughbred Financial Services's JAZZ Position: Q3 2026 in Review

Thoroughbred Financial Services increased its Jazz Pharmaceuticals (JAZZ) stake by 5.8% in Q3 2026, buying an estimated $96.8K and bringing the position to 7,106 shares worth $1.64M. The position accounts for 0.08% of the portfolio, ranked #211.

Thoroughbred Financial Services first reported a position in JAZZ in Q1 2026 and has held it in 3 quarters since. 664 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Thoroughbred Financial Services held 7,106 shares of Jazz Pharmaceuticals worth $1.64M as of Q3 2026.
  • Thoroughbred Financial Services bought 392 Jazz Pharmaceuticals shares in Q3 2026, an estimated $96.8K.
  • Jazz Pharmaceuticals made up 0.08% of Thoroughbred Financial Services's portfolio in Q3 2026, its #211 holding.
  • Thoroughbred Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 664 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Thoroughbred Financial Services's 13F filing for Q3 2026, filed 9 Nov 2026.